Sort
21,453 grants matching “tuberculosis”
Investigating Multiple PK and PD Relationships for TB-HIV (IMPPRove TB-HIV)
$817,252Kelly E. Dooley · Vanderbilt University Medical Center · R56 · FY2023 · AI
M. tuberculosis carbon metabolism during infection
$817,108Sabine Ehrt · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
In vivo assessment and optimization of phage PK/PD for the treatment of pulmonary Mycobacterium abscessus infection
$816,995Miriam S. Braunstein · Colorado State University · R01 · FY2024 · AI
Structural characterization of MCE transport systems from Mycobacterium tuberculosis
$816,793Gira Bhabha · New York University School Of Medicine · R01 · FY2023 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$816,626Weston R Ruhrig · Pennsylvania State Dept Of Health · U52 · FY2008 · PS
TUBERCULOSIS ELIMINATION AND LABORATORY
$816,626Weston R Ruhrig · Pennsylvania State Dept Of Health · U52 · FY2009 · PS
I TITRATE PC: An Implementation based Community Health Worker Intervention to address Disparities in Palliative Care
$816,621Fabian M Johnston · Johns Hopkins University · R01 · FY2022 · MD
Video DOT and Economic Incentives to promote adherence to LTBI therapy
$816,546Maunank Shah · Johns Hopkins University · R01 · FY2022 · AI
Hodgkin Lymphoma in PLWH in South Africa: TB, EBV, and Tumor Molecular Markers
$816,273Richard F. Ambinder · Johns Hopkins University · R01 · FY2021 · CA
Measuring Intralesional Drug Exposures in Cavitary TB using Noninvasive In Vivo PET Imaging
$816,236Sanjay Jain · Johns Hopkins University · R01 · FY2020 · AI
The PHASES Project: Pregnancy and HIV/AIDS-Seeking Equitable Study
$815,691Anne Drapkin Lyerly · Univ Of North Carolina Chapel Hill · R01 · FY2015 · AI
Bone health in perinatally HIV-infected South African children on antiretrovirals
$815,535Stephen M Arpadi · Columbia University Health Sciences · R01 · FY2012 · HD
Lactoferrin Modulation of Granuloma Pathology
$815,321Jeffrey K Actor · Pharmareview Corporation · R42 · FY2017 · AI
Mapping and dissecting the role of antibodies in Mtb control
$815,165Galit Alter · Massachusetts General Hospital · R56 · FY2020 · AI
Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring
$814,778Anna M Mandalakas · Baylor College Of Medicine · R01 · FY2022 · AI
Hodgkin Lymphoma in PLWH in South Africa: TB, EBV, and Tumor Molecular Markers
$814,364Richard F. Ambinder · Johns Hopkins University · R01 · FY2022 · CA
Expansion of SARS-CoV-2 Testing Supplement, Chicago Clinical Trials Unit
$814,136Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2020 · AI
Transmission of HIV-Associated XDR TB in Rural South Africa
$813,935Nippie Sarita Shah · Albert Einstein College Of Medicine · R01 · FY2010 · AI
Short-course rifapentine for TB prevention for all: clinical pharmacology matters
$813,899Kelly E. Dooley · Vanderbilt University Medical Center · R37 · FY2025 · AI
Cavity and Granuloma Oriented Inflammation and Tissue Pharmacokinetics in Pulmonary Tuberculosis (COOK TB)
$813,868Russell Ryan Kempker · Emory University · R01 · FY2023 · AI
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$813,838William Ramses Bishai · Johns Hopkins University · R01 · FY2021 · AI
Genetic and hormonal mechanisms mediating sex differences in TB and TB-HIV
$813,838William Ramses Bishai · Johns Hopkins University · R37 · FY2025 · AI
Genetic and hormonal mechanisms mediating sex differences in TB and TB-HIV
$813,838William Ramses Bishai · Johns Hopkins University · R37 · FY2022 · AI
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$813,838William Ramses Bishai · Johns Hopkins University · R01 · FY2024 · AI
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$813,838William Ramses Bishai · Johns Hopkins University · R01 · FY2022 · AI